Thiel Macro LLC

Institutional investor · Portfolio as of Q2 2017

Top Holdings17 positions

Checking export access…
Activity:
IWM
IWM
PUT

ISHARES TR

610,000$86M24.6%———
New
—
??
PROSHARES TR II
PUT
Delisted
950,000$76.6M21.9%———
New
—
SPY
SPY
PUT

STATE STR SPDR S&P 500 ETF T

200,000$48.4M13.8%———
New
—
200,000$27.5M7.9%———
New
—
BCSFL
BCSFL
PUT
Delisted

BARCLAYS BK PLC

1.8M$22.3M6.4%———
Unchanged
—
EEM
EEM
PUT

ISHARES TR

432,500$17.9M5.1%———
Decreased
—
FXI
FXI
PUT

ISHARES TR

420,000$16.7M4.8%———
New
—
100,000$13.8M3.9%———
New
—
KRE
KRE
ETF

SPDR SERIES TRUST

200,000$11M3.1%$43.230.00%
1 qtr
New
80
XLF
XLF
PUT

SELECT SECTOR SPDR TR

312,500$7.7M2.2%———
New
—
HYG
HYG
PUT

ISHARES TR

83,000$7.3M2.1%———
New
—
700,000$6.8M2.0%———
New
—
OIH
OIH
ETF

VANECK VECTORS ETF TR

125,000$3.1M0.9%$474.34-10.44%
2 qtrssince 2017-Q1
Increased
63
XOP
XOP
ETF

SPDR SERIES TRUST

54,000$1.7M0.5%$105.840.00%
1 qtr
New
46
ITA
ITA
ETF

ISHARES TR

10,000$1.6M0.5%———
Unchanged
0
EWZ
EWZ
PUT

ISHARES INC

18,000$614,0000.2%———
New
—
GREK
GREK
ETF

GLOBAL X FDS

30,000$303,0000.1%$23.390.00%
1 qtr
New
35
$349.3M
AUM
17
Positions
Q2 2017
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q2'17
New73%Increased0%Decreased20%Exited7%
Composition
Equity vs derivatives
Equity5%Puts89%Calls6%
Holding period
Avg 2.5 quarters
<1Q53%1-4Q24%1-2Y0%2Y+24%

Thiel Macro LLC manages $349.3M across 17 positions as of Q2 2017. Top holdings: IWM puts (24.6%), PROSHARES TR II puts (21.9%), SPY puts (13.8%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.

Q2 2017 Summary

Added KRE, XOP and GREK; exited XLF and AMJ; increased 1, led by OIH (+65,000 shares). Top move: KRE (NEW, conviction 80). Portfolio: $349M across 17 positions.

Top holdings by portfolio weight

Total AUM$18M
KRE3.15%
OIH0.89%
XOP0.49%
ITA0.45%
GREK0.09%
AMJ0.00%
XLF0.00%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L26
Conviction71
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used